Dean, Linda EMacfarlane, Gary JJones, Gareth T2018-08-012018-08-012018-01-01Dean, L E, Macfarlane, G J & Jones, G T 2018, 'Five Potentially Modifiable Factors Predict Poor Quality of Life in Ankylosing Spondylitis : Results from the Scotland Registry for Ankylosing Spondylitis', Journal of Rheumatology, vol. 45, no. 1, pp. 62-69. https://doi.org/10.3899/jrheum.1604110315-162XORCID: /0000-0003-2322-3314/work/72631735ORCID: /0000-0003-0016-7591/work/83704045http://hdl.handle.net/2164/10848We thank all the clinicians and research nurses who facilitated recruitment and data collection. In particular, we thank the Scotland Registry for Ankylosing Spondylitis (SIRAS) steering committee, especially Professor Roger Sturrock (chair) and Dr. David Marshall (vice-chair). We also thank the SIRAS coordinating center study team, in particular Elizabeth Ferguson-Jones, Giles O’Donovan, Nabi Moaven-Hashemi, and Flora Joyce. GTJ has received research funding from AbbVie, Pfizer, and UCB. GJM has received research funding from AbbVie, Pfizer, and UCB in the form of unrestricted or investigator initiated grants. GJM also chairs a Pfizer research grant panel, for which he receives an honorarium. LED conducted the analysis while funded by an MRC PhD studentship.8146446engAnkylosing spondylitisspondyloarthritisEpidemiologyquality of lifeASQOLR Medicine (General)Medical Research Council (MRC)R1Journal article10.3899/jrheum.160411451